The study is designed as a randomized, double-blind, parallel-group, multi centre study comparing perception and tolerability of investigational product and comparator. In the randomized part of the study the subjects will be given either LoFric Primo (POBE) or the comparator LoFric Primo (PVC) for use over 4 weeks. The hypothesis is that subject perception and satisfaction of POBE is equal to or better than for PVC.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
195
LoFric Primo (POBE) single-use urinary catheter
LoFric Primo (PVC) single-use urinary catheter
Medical University of Vienna, Department of Urology
Vienna, Austria
NRZ Greifswald
Greifswald, Germany
Kliniken Maria Hilf GmbH, Zentrum für Kontinenz und Neuro-Urologie, Krankenhaus St. Franziskus
Subject's Perception Regarding Handling of Test Catheter Before Insertion
Subject's perception regarding handling of test catheter before insertion, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
Time frame: At 4 weeks
Subject's Perception Regarding Handling of Test Catheter at Insertion
Subject's perception regarding handling of test catheter at insertion, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
Time frame: At 4 weeks
Subject's Perception Regarding Handling of Test Catheter at Withdrawal
Subject's perception regarding handling of test catheter at withdrawal, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
Time frame: At 4 weeks
Subject's Perception Regarding Handling of Test Catheter After Withdrawal
Subject's perception regarding handling of test catheter after withdrawal, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
Time frame: At 4 weeks
Subject's General Satisfaction With Test Catheter
Subject's general satisfaction with test catheter, measured by mean score on a scale from 1 (Very satisfied) to 5 (Absolutely not satified)
Time frame: At 4 weeks
Subject's Sensation When Using Test Catheter
Subject's sensation when using test catheter, measured by mean score on a scale from 1 (Comfortable) to 6 (Severe pain)
Time frame: At 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Mönchengladbach, Germany
BG-Klinik Tübingen
Tübingen, Germany
Ospedale Careggi, Unità Spinale
Florence, Italy
Primario U.O. Neuro-Urologia, Direttore Dipartimento delle Mielolesioni
Torino, Italy
Ziekenhuis Lievensberg, Afdeling Urologie
Bergen op Zoom, Netherlands
Albert Schweitzer Ziekenhuis, Locatie Dordwijk
Dordrecht, Netherlands
Catharina Ziekenhuis
Eindhoven, Netherlands
Radboud Univesity Nijmegen Medical Centre
Nijmegen, Netherlands
...and 3 more locations